多發(fā)性硬化癥(Multiple sclerosis)是一種影響包括大腦、視神經(jīng)和脊髓等中樞神經(jīng)系統(tǒng)的疾病。來自哈佛大學(xué)附屬研究院安·羅姆尼中心研究神經(jīng)系統(tǒng)疾病的一群專家開始研究為什么多發(fā)性硬化癥會(huì)隨著季節(jié)的變化而變化——隨著白天時(shí)間的變短而有所改善。
For patients and clinicians alike, its long been a mystery: Why do symptoms of multiple sclerosis (MS) seem to get better in the winter and worse in the summer? A group led by Francisco Quintana and collaborators have found an explanation that could lead to a deeper understanding of the disease and more targeted treatment options for patients. By looking first broadly at possible environmental factors and then deeply at preclinical models of MS, the research team found that melatonin—a hormone involved in regulating a persons sleepwake cycle—may influence MS disease activity. The team reports its findings this week in Cell.
“We know that for multiple sclerosis and most autoimmune diseases, both genetic and environmental factors play an important role, but in the last decade, most research has focused only on the genetic side of the equation,” said cocorresponding author Quintana. “But we wanted to see what environmental factors would reveal to us about this disease. We knew that MS disease activity changed with the seasons. What weve uncovered offers an explanation for why that is the case.”
Quintana and his colleagues began by studying patients. The team found that during the fall and winter, the group of 139 relapsing remitting MS patients they studied experienced a significant improvement in symptoms—a phenomenon thats been observed in previous studies. The team then explored a variety of environmental factors that have been proposed as possibly linked to MS symptoms, including vitamin D levels, UV incidence, and upper respiratory tract infections. But the factor that was consistently associated with severity of MS symptoms was melatonin. Melatonin levels are known to correlate with the durations of days—during the longer days of the spring and summer, levels are lower; during the shorter days of the fall and winter, levels are higher.
Based on this observation, the team tested this lead in the lab, studying the role that melatonin may play on a cellular level. Using both a mouse model and human cells, they investigated the effects of melatonin on certain types of cells known to play a role in the immune response that leads to MS symptoms. The team found that melatonin affected the roles of two kinds of cells that are important in MS disease progression: pathogenic T cells, which directly attack and destroy tissue, and regulatory T cells, which are supposed to keep pathogenic T cells in check.
“We found that melatonin has a protective effect,” said Quintana. “It dampens the immune response and helps keep the bad guys—or pathogenic T cells—at bay.”
Although melatonin is available over the counter, it has significant drawbacks, including causing unwanted drowsiness. The teams goal is to tease apart the molecular mechanisms that underlie melatonins role in order to develop targeted, nontoxic drugs that are safe and effective with minimal side effects.
“In the future, melatonin or its derivatives may be used in MS patients after appropriate clinical trials are conducted and dosage is established,” said Quintana. “However, extreme caution should be exercised: Our data do not show that melatonin or its analogs are effective in treating MS.”
1. Which of the following descriptions is not right?
A. Melatonin dampens the immune response and helps keep pathogenic T cells at bay.
B. The team found that pathogenic T cells directly attack and destroy tissue.
C. The research team has no idea whether MS disease changed with the season.
D. It is known that melatonin levels are associated with the durations of days.
2. What can be inferred from the article?
A. Most research focus only on the genetic side because environmental factors are not important.
B. The research has developed targeted, nontoxic drugs that are safe and effective with no side effects.
C. Why symptoms of MS seem to get better in the winter and worse in the summer is a myster.
D. Scientists havent found out whether melatonin or its analogs are effective in treating MS so far.
3. Which of the following factors is consistently linked to severity of MS symptons?
A. Vitamin D levels. B. UV incidence.
C. Upper respiratory. D. Melatonin.
4. Which of the following word can best replace the underlined word in paragrah three?
A. Avoiding. B. Decreasing.
C. Relieving. D. Changing.
5. What is the main idea of this article?
A. Why MS symptoms may improve as days get shorter?
B. What is multiple sclerosis (MS)?
C. How to cure patients of multiple sclerosis (MS).
D. A deadly disease
參考答案
1—5 CDDCA
(作者:潘井正,江蘇省灌南高級(jí)中學(xué))
心靈驛站
高三生如何擺脫強(qiáng)迫癥困擾
很多學(xué)子說自己很想學(xué)習(xí),卻越學(xué)越焦慮,越學(xué)成績?cè)较陆?,以致于越學(xué)越學(xué)不進(jìn)去,甚至產(chǎn)生強(qiáng)迫癥、抑郁癥等嚴(yán)重心理問題。
高中生一方面面臨巨大的學(xué)習(xí)壓力;另一方面心身處于急劇變化階段,再加上心智不成熟,很容易產(chǎn)生心理上的困擾,導(dǎo)致影響學(xué)習(xí)。如內(nèi)心自卑;內(nèi)心承受力弱;人際交往困擾;青春期兩性心理困擾等問題不能化解,都會(huì)對(duì)學(xué)習(xí)產(chǎn)生極大的不良影響,為此,高中生要學(xué)會(huì)自我調(diào)整:
第一,根據(jù)自己的具體情況制定一個(gè)合理的目標(biāo)
順其自然一些,不是所有的鳥都是鳳凰,也并不需所有的人都要向東南飛。三千六百行,行行出狀元。
第二,學(xué)會(huì)釋放自己的情緒
我們必須認(rèn)識(shí)到,一定的緊張和焦慮對(duì)于我們的學(xué)習(xí)不但沒有害處,相反是有好處的。問題是我們必須把這種緊張和焦慮的心理調(diào)整在可以控制的范圍以內(nèi),這種壓力必須轉(zhuǎn)化為動(dòng)力才能促進(jìn)我們的學(xué)習(xí)。當(dāng)壓力過大的時(shí)候,通過轉(zhuǎn)移注意力或者參加劇烈運(yùn)動(dòng)適當(dāng)釋放和緩解這種壓力,可以幫助我們把緊張和焦慮調(diào)整到一個(gè)合理的水平。
第三,制定切實(shí)可行的復(fù)習(xí)計(jì)劃
制定復(fù)習(xí)計(jì)劃時(shí),按下面的環(huán)節(jié)進(jìn)行,通??梢允盏奖容^好的效果:理解——思考——運(yùn)用——記憶——聯(lián)系。首先,學(xué)會(huì)看書,看書是實(shí)現(xiàn)理解和思考兩個(gè)過程的必經(jīng)途徑。其次,運(yùn)用所學(xué)的知識(shí)解題,是鞏固和輔助記憶的過程。各門學(xué)科之間具有橫向聯(lián)系,同一學(xué)科內(nèi)部的各部分知識(shí)之間又具有縱向聯(lián)系。因此,最后一點(diǎn)就是要注重各部分知識(shí)之間的聯(lián)系,將知識(shí)系統(tǒng)化,形成知識(shí)網(wǎng)絡(luò)。
第四,應(yīng)及時(shí)向親人、師長或心理輔導(dǎo)人員述說,請(qǐng)求幫助。必要時(shí)求助專業(yè)心理咨詢師進(jìn)行有效的心理調(diào)整
學(xué)習(xí)本身不是問題,學(xué)習(xí)更不是能力的問題,關(guān)鍵是健全人格的培養(yǎng)和擁有良好的學(xué)習(xí)心態(tài)和學(xué)習(xí)方法。教育首先要讓孩子成為一個(gè)堂堂正正的健康人,不為學(xué)奴,學(xué)為我用,成人才能真正成才。